Single-turnover kinetic analysis of non-LTR retrotransposition defines the mechanism and rate constants governing each step

Tyler L Dangerfield,Jun Zhou,Thomas Eickbush,Kenneth A. A Johnson
DOI: https://doi.org/10.1101/2024.08.28.610141
2024-08-29
Abstract:Site specific retrotransposon-mediated gene therapy has the potential to revolutionize medicine by allowing insertion of large gene cargos. Despite decades of effort, the reaction sequence remains to be fully elucidated limiting the ability to engineer improved activity for gene insertion. Here we provide a kinetic/mechanistic framework for R2 non-LTR retrotransposition. Single turnover measurements and global data fitting defined the rate constants for each step in the pathway involving 1st-strand DNA cleavage to provide a DNA primer, reverse transcription to copy the RNA, 2nd-strand DNA cleavage to provide the second primer, and 2nd-strand synthesis to make duplex cDNA. Sequence analysis of the cDNA confirms accurate replication of the 1400 nt RNA used in this study. This represents the only complete analysis of the reaction sequence and first observation of 2nd-strand synthesis in vitro. We provide a kinetic framework to understand non-LTR retrotransposition, which provide a basis to engineer improved activity.
Biochemistry
What problem does this paper attempt to address?
The paper attempts to address the issue of unclear reaction sequences during the gene insertion process of non-long terminal repeat (non-LTR) retrotransposon R2. Specifically, the paper defines the mechanisms and rate constants for each step of the R2 non-LTR retrotransposon through single-turnover kinetic analysis, including first-strand DNA cleavage, reverse transcription, second-strand DNA cleavage, and second-strand synthesis. These steps are crucial for understanding the entire reaction process of non-LTR retrotransposons and will aid in improving their gene insertion efficiency in the future. ### Main Issues: 1. **Unclear Reaction Sequence**: Despite decades of research, the reaction sequence of non-LTR retrotransposons has not been fully elucidated, limiting the ability to engineer their activity. 2. **Low Efficiency and Variability**: The insertion efficiency of non-LTR retrotransposons is relatively low, often resulting in variable 5' and 3' ends and extensive 5' truncations. This limits their application as gene insertion tools. ### Solutions: - **Single-Turnover Kinetic Analysis**: By measuring single-turnover kinetics and fitting global data, the rate constants for each step were defined. - **Detailed Experimental Design**: Using specific mRNA and target DNA oligonucleotides, the concentration of enzyme active sites and DNA binding affinity were quantified, identifying the important roles of two specific RNA fragments in DNA cleavage and synthesis reactions. - **Complete Reaction Observation**: For the first time, the second-strand synthesis was directly observed, generating complete double-stranded cDNA products. ### Main Findings: - **First-Strand Cleavage**: 3' RNA significantly stimulates first-strand cleavage, but approximately 25% of the DNA is in a non-productive state. - **Second-Strand Cleavage**: 5' RNA is crucial for second-strand cleavage but is inhibited in the presence of 3' RNA. - **TPRT Reaction**: The first-strand cleavage product initiates reverse transcription with an average polymerization rate of 6.8 nt/s. - **Second-Strand Synthesis**: The second-strand synthesis was directly observed for the first time, although with low efficiency (about 20%), providing an important basis for quantitative analysis. ### Significance: - **Mechanism Understanding**: Provides a complete kinetic framework for the insertion mechanism of non-LTR retrotransposon R2, filling a long-standing gap in understanding this process. - **Foundation for Engineering**: Lays the groundwork for future engineering efforts to improve the gene insertion efficiency of non-LTR retrotransposons in human cells. In summary, through detailed kinetic analysis, this paper addresses key issues in the insertion mechanism of non-LTR retrotransposon R2, providing important theoretical and technical support for future gene therapy applications.